4 Top Health Care Stocks To Watch Now Ahead Of Debt Ceiling Talks dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.
I-Mab
I-Mab is a clinical-stage biopharmaceutical company that commits to the discovery, development, and commercialization of novel or highly differentiated biologics. The company aims to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. As a company not involved in COVID-19 vaccines, the health care company stock has been performing extremely well. Impressively, it has risen by more than 220% over the past year with its bullish trend still intact.
Investors have been keeping their eyes on IMAB stock in response to the company’s early data on Uliledlimab/Atezolizumab combo in advanced cancer settings. More detailed data of the trial will be unveiled at the 2021 American Society of Clinical Oncology Annual Meeting which will be taking place next month.
Taysha Gene Therapies Inc (NASDAQ: TSHA)
Regeneron Pharmaceuticals Inc (NASDAQ: REGN)Moderna Inc
Moderna is an mRNA vaccine company that has been one of the biggest winners in the healthcare sector. The company is one of the first in the world to receive the Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its coronavirus vaccine. In addition, its mRNA science is also contributing to the development of new drugs in the foreseeable future. For example, Moderna is developing therapeutics for infectious diseases, immuno-oncology, and cardiovascular diseases.Â
Source: TD Ameritrade TOS
On Monday, contract drugmaker Rovi revealed that it will be making active ingredients for Modernaâs COVID-19 vaccine, extending an existing agreement to bottle the vaccine. Moderna has said it will make at least 700 million doses of vaccine in 2021, including from plants in Europe and the United States. The company is not resting on its laurels and is acti